Checked · GMP unchanged since
Moneyview IPO GMP is ₹14 as of 10:00 am — expected profit +41.2% on the ₹34 upper band. The premium has ranged ₹0–₹14 across 50 readings.
GMP is an unofficial, unregulated datapoint reported by third parties — not a price, a forecast, or investment advice.
Detailed financials for this issue aren’t available yet.
| # | Anchor investor | Shares | % of book | ₹ Cr |
|---|---|---|---|---|
| 1 | SBI BANKING & FINANCIAL SERVICES FUND | 1,47,06,027 | 15.27% | 50.00 |
| 2 | ICICI PRUDENTIAL SMALLCAP FUND | 88,23,528 | 9.16% | 30.00 |
| 3 | GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO | 88,23,528 | 9.16% | 30.00 |
| 4 | MIRAE ASSET MIDCAP FUND | 67,64,499 | 7.02% | 23.00 |
| 5 | INDIA ACORN FUND LTD | 67,64,499 | 7.02% | 23.00 |
| 6 | ISIF EQUITY EX-TOP 100 LONG-SHORT FUND | 58,82,499 | 6.11% | 20.00 |
| 7 | HDFC MUTUAL FUND - HDFC INNOVATION FUND | 58,82,499 | 6.11% | 20.00 |
| 8 | HDFC MUTUAL FUND - HDFC TECHNOLOGY FUND | 58,82,499 | 6.11% | 20.00 |
| 9 | ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SUN LIFE BANKING | 55,87,911 | 5.8% | 19.00 |
| 10 | QUANT MUTUAL FUND - QSIF HYBRID LONG-SHORT FUND | 52,20,558 | 5.42% | 17.75 |
| 11 | MOTILAL OSWAL MULTI CAP FUND | 48,61,584 | 5.05% | 16.53 |
| 12 | 360 ONE EQUITY OPPORTUNITY FUND- SERIES 2 | 37,49,568 | 3.89% | 12.75 |
| 13 | HDFC LIFE INSURANCE COMPANY | 29,42,793 | 3.06% | 10.01 |
| 14 | AMUNDI FUNDS ASIA EQUITY FOCUS | 29,41,470 | 3.05% | 10.00 |
| 15 | HDFC MUTUAL FUND - HDFC RETIREMENT FUND - EQUITY PLAN | 29,41,029 | 3.05% | 10.00 |
| 16 | MOTILAL OSWAL FINANCIAL SERVICES FUND | 19,02,915 | 1.98% | 6.47 |
| 17 | 360 ONE EQUITY OPPORTUNITY FUND - SERIES 4 | 14,70,735 | 1.53% | 5.00 |
| 18 | AND FINANCIAL SERVICES FUND ADITYA BIRLA SUN LIFE MUTUAL FUND - APEX EQUITY EX-TOP 100 LONG-SHORT | 5,88,294 | 0.61% | 2.00 |
| 19 | FUND ADITYA BIRLA SUN LIFE MUTUAL FUND - APEX EQUITY LONG-SHORT FUND | 2,94,147 | 0.3% | 1.00 |
| 20 | ADITYA BIRLA SUN LIFE MUTUAL FUND - APEX HYBRID LONG-SHORT FUND | 2,94,147 | 0.3% | 1.00 |
Ranked by size of allocation; every anchor in an issue pays the same price, so the ranking is the same whether read in shares, rupees or share of the book. Anchor investors are allotted shares one day before the issue opens, at a price fixed on that day, and are locked in afterwards (30 days for half the allocation, 90 days for the rest). Read straight from the company’s own Anchor Allocation intimation letter filed with the exchanges — names appear exactly as printed there. Percentages are the filer’s own and total the anchor portion, not the whole issue. View the filed letter
| Application | Shares | Amount at ₹34 |
|---|---|---|
| Retail (min)1 lot | 441 | ₹14,994 |
| Retail (max)13 lots | 5,733 | ₹1,94,922 |
| sHNI (min)14 lots | 6,174 | ₹2,09,916 |
| bHNI (min)67 lots | 29,547 | ₹10,04,598 |
One lot is 441 shares, so a single application at the ₹34 cut-off costs ₹14,994. Retail applications are capped at ₹2,00,000, which is 13 lots for this issue. Amounts are shown at the upper band because applications are made at the cut-off price.
Moneyview Limited is a digital financial services platform that provides access to a suite of financial products through a network of Financial Partners. The company offers personal loans, credit cards, insurance, digital gold, and fixed deposits. It operates primarily through its NBFC subsidiary, Whizdm Finance Private Limited. Moneyview Limited is headquartered in Bengaluru, Karnataka, India.
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Moneyview Limited, the registrar is MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) — allotment is finalised in the days between the issue closing on 28 Sept 2026 and listing on 01 Oct 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: MUFG Intime. Your bank will also show the blocked amount released if shares were not allotted.
The listing price is discovered by demand in the pre-open session and routinely differs from any grey-market quote. Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.
The Moneyview Limited shares are scheduled to list on 1 October 2026 on NSE. The listing price is discovered in a special pre-open session from 9:00 am and normal trading begins at 10:00 am IST.
Grey-market dealers are quoting a premium of ₹14 over the ₹34 band, which implies ₹48. GMP is an unofficial, unregulated datapoint reported by third parties — not a price, a prediction, or investment advice. The actual listing price is set by demand in the pre-open session.
On listing day the exchange runs a special pre-open session for the new stock from 9:00 am IST in which orders are collected and the listing price is discovered; continuous trading in the shares begins at 10:00 am IST.
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹14 on a ₹34 upper band means the grey market is dealing at ₹48.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.